Opendata, web and dolomites

CTI

A novel, efficient and minimally invasive medical procedure to treat anastomotic leakage during colorectal cancer surgery.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CTI project word cloud

Explore the words cloud of the CTI project. It provides you a very rough idea of what is the project "CTI" about.

disposable    rates    disease    leakage    right    decrease    start    invention    trl7    surgical    loop    feces    tests    91m    energy    efficient    safer    18    permits    company    complications    innovation    improvements    hires    italy    transport    roll    stay    anastomotic    committee    treatment    least    environmental    impacts    team    nowadays    positive    people    market    mortality    2018    cancer    anastomoses    2025    area    worried    97    defunction    prototype    catheter    readiness    medical    patients    technique    tumor    alternative    decided    50    colorectal    ago    2014    round    reduce    it    authorized    hospital    630    ileostomy    diagnosed    patient    pouches    time    1992    99    recovery    plastic    ethical    spain    connected    hospitals    period    modena    surgery    experimental    aragon    tecnoline    invest    animal    transcaecal    founded    boost    cti    successfully    diminish    turnover    ebola    220    population    despite    risk    passed    started    clinical    replace    reoccurrence    morbidity    moment    launched    solution    die    translated    preparing    rectal   

Project "CTI" data sheet

The following table provides information about the project.

Coordinator
TECNOLINE SPA 

Organization address
address: VIA GELATTI 11/A
city: CONCORDIA SULLA SECCHIA
postcode: 41033
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website https://www.tecnolinesrl.org/shop/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECNOLINE SPA IT (CONCORDIA SULLA SECCHIA) coordinator 50˙000.00

Map

 Project objective

It is estimated that in 2018, 97,220 people will be diagnosed with colorectal cancer and that about 50,630 people will die from this disease; making treatment this cancer to be of growing importance nowadays. Despite improvements in the area of surgical treatment of the tumor, there are still many risk factors connected with mortality, recovery and reoccurrence rates, as well as complications (like anastomotic leakage).

After having successfully launched an innovation that permits the transport of Ebola patients in 2014, Tecnoline (a medical company founded in 1992 in Modena, Italy) decided to invest into innovation development for the surgical treatment of colorectal cancer. Three years ago the team started developing a prototype of the Catheter for Transcaecal Ileostomy (CTI), an alternative technique to loop ileostomy to defunction low rectal anastomoses. Our company conducted a positive round of animal and clinical tests.

The new invention is capable to decrease morbidity and mortality rates due to anastomotic leakage and surgery complications; diminish the hospital stay and ‘worried well’ by 50%; reduce the operating time by at least 50% and up to 99% leakage of feces. It also have a positive environmental impact since it replace the disposable plastic pouches and reduce energy use and other impacts connected with the patients stay in the hospitals. Finally, this invention has the potential to boost the company growth, translated into 8.91M€ of turnover (2025) and 40 new hires for the development period.

Tecnoline was authorized by the Ethical Committee of Aragon (Spain) to implement CTI in a patient population in Aragon (18 patients). The solution has just passed through the experimental process and therefore reaches TRL7. Thus, it is the right moment to start preparing the CTI market readiness and roll-out to provide the medical sector with a unique solution that makes treatment of colorectal cancer patients safer, more efficient and effective.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CTI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CTI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More  

PANDa (2019)

Portable ANalyser for Detection of metal micropollutants in water

Read More  

COOLSOE (2019)

ADAPTABLE, COMPACT AND MAINTENANCE-FREE COOLING SYSTEMS FOR ONBOARD EQUIPMENT

Read More